Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the antihypertensive effects of Hyzaar and its impact on cognitive function in hypertensive patients is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyzaar (losartan/hydrochlorothiazide)

Snippet

Sponsor: Organon and Co | Conditions: Hypertension | Phase 3 | Status: COMPLETED